Effects of Instrument Assisted Soft Tissue Mobilization Regarding Range of Motion and Lower Extremity Power
NCT ID: NCT06610058
Last Updated: 2024-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2024-01-08
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does IASTM treatment have an effect on range of motion (ROM) as measured in the hip, knee and ankle?
* Does IASTM treatment have an effect on lower extremity power? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change range of motion and/or lower extremity power.
Participants will:
* Complete a questionnaire on medical history and injury background
* Have hip, knee and ankle range of motion (ROM) measurements taken on both lower extremities using a goniometer
* Complete three trials of vertical jump testing using a Fleage Floor standing vertical jump measurement tester with one warm up first
* Complete three trials of horizontal jump testing using a Woanger 12'x2.5' long jump mat and verified by a secondary measure using a tape measure with one warm up first
* Be randomly assigned to either IASTM first treatment group or the wait/control first group
* Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the hamstrings, quadriceps, gastroc/soleus complex, and Achilles tendon using the HG8-Scanner tool for 15 strokes in each direction. Then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction.
* Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when completing the control treatment.
* Complete hip, knee and ankle range of motion and vertical and horizontal jump measure testing at the end of the first session.
* Return within fourteen days after the first session in order to undergo the opposite experience (IASTM first means wait/control second and vice versa).
* Undergo the same baseline pre-test measurements for range of motion and vertical and horizontal jump measure testing as the first session.
* Experience the opposite treatment for the same time period as the first session.
* Undergo the post-test range of motion and vertical and horizontal jump measure testing at the end of the second session for data comparison.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Gait
NCT06612983
The Effects of IASTM and Proprioception
NCT03023943
Does the Addition of Manual Therapy Techniques Increase Gastrocnemius/Soleus Length More Than Stretching Alone?
NCT01856972
Study on the Effect of Exercise Intervention Combined With Physical Therapy on Chronic Ankle Instability Symptoms
NCT06251414
Changes in the Ankle Range of Motion Following Subtalar Joint Manipulation
NCT00981331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IASTM First
This arm of the study received IASTM treatment on the first day and the wait/control on the second day of the study
Instrument Assisted Soft Tissue Mobilization first Control second
Instrument assisted soft tissue mobilization was utilized first on day one and wait-control was completed on second day.
Wait/control First
This arm of the study waited (was the control) on the first day and received IASTM treatment on the second day of the study.
Control first Instrument Assisted Soft Tissue Mobilization second
This intervention involved waiting for 20 minutes between pre-test and post-test on day one and having Instrument Assisted Soft Tissue Mobilization on day two.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Instrument Assisted Soft Tissue Mobilization first Control second
Instrument assisted soft tissue mobilization was utilized first on day one and wait-control was completed on second day.
Control first Instrument Assisted Soft Tissue Mobilization second
This intervention involved waiting for 20 minutes between pre-test and post-test on day one and having Instrument Assisted Soft Tissue Mobilization on day two.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Neurological disorders
* Acute lower extremity injury such as sprain or strain
* Acute lower extremity pain causing gait deviation
* Any type of lower extremity fracture within the past 12 months
* Lumbar disc pathology with radicular symptoms
* Use of blood thinning or clotting medications
* Known connective tissue disorder
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minot State University
OTHER
Beth Marschner
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beth Marschner
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beth Marschner, DPT
Role: PRINCIPAL_INVESTIGATOR
Minot State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minot State University
Minot, North Dakota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2428
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.